KR101710766B1 - 세포 배양물의 사전-예정된 비-피이드백 조절된 연속 공급 - Google Patents
세포 배양물의 사전-예정된 비-피이드백 조절된 연속 공급 Download PDFInfo
- Publication number
- KR101710766B1 KR101710766B1 KR1020147005482A KR20147005482A KR101710766B1 KR 101710766 B1 KR101710766 B1 KR 101710766B1 KR 1020147005482 A KR1020147005482 A KR 1020147005482A KR 20147005482 A KR20147005482 A KR 20147005482A KR 101710766 B1 KR101710766 B1 KR 101710766B1
- Authority
- KR
- South Korea
- Prior art keywords
- feed
- continuous
- cell culture
- cell
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004113 cell culture Methods 0.000 title claims abstract description 88
- 238000000034 method Methods 0.000 claims abstract description 107
- 230000012010 growth Effects 0.000 claims abstract description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 106
- 239000008103 glucose Substances 0.000 claims description 106
- 235000015097 nutrients Nutrition 0.000 claims description 68
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 210000004962 mammalian cell Anatomy 0.000 claims description 14
- 235000001014 amino acid Nutrition 0.000 claims description 13
- 229940024606 amino acid Drugs 0.000 claims description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 7
- 235000006286 nutrient intake Nutrition 0.000 claims description 5
- 241000699802 Cricetulus griseus Species 0.000 claims description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 239000000758 substrate Substances 0.000 abstract description 32
- 239000000523 sample Substances 0.000 abstract description 5
- 238000012423 maintenance Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 117
- 230000006870 function Effects 0.000 description 101
- 238000004519 manufacturing process Methods 0.000 description 32
- 230000008569 process Effects 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 23
- 235000018102 proteins Nutrition 0.000 description 21
- 230000010261 cell growth Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 16
- 230000001976 improved effect Effects 0.000 description 14
- 230000003833 cell viability Effects 0.000 description 12
- 239000010432 diamond Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 10
- 230000014616 translation Effects 0.000 description 10
- 238000013459 approach Methods 0.000 description 7
- 238000012384 transportation and delivery Methods 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 238000009795 derivation Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 229910003460 diamond Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000012840 feeding operation Methods 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000004836 empirical method Methods 0.000 description 3
- 235000021048 nutrient requirements Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108091006020 Fc-tagged proteins Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 238000011021 bench scale process Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000009123 feedback regulation Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 238000002103 osmometry Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011165 process development Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960000160 recombinant therapeutic protein Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/32—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of substances in solution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/38—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of metabolites or enzymes in the cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/40—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161535809P | 2011-09-16 | 2011-09-16 | |
| US61/535,809 | 2011-09-16 | ||
| PCT/US2012/055552 WO2013040444A1 (en) | 2011-09-16 | 2012-09-14 | Pre-programmed non-feedback controlled continuous feeding of cell cultures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140044396A KR20140044396A (ko) | 2014-04-14 |
| KR101710766B1 true KR101710766B1 (ko) | 2017-02-27 |
Family
ID=46964067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147005482A Active KR101710766B1 (ko) | 2011-09-16 | 2012-09-14 | 세포 배양물의 사전-예정된 비-피이드백 조절된 연속 공급 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9803166B2 (https=) |
| EP (1) | EP2756069B1 (https=) |
| JP (4) | JP2014526265A (https=) |
| KR (1) | KR101710766B1 (https=) |
| CN (1) | CN103946366B (https=) |
| AU (1) | AU2012308335A1 (https=) |
| BR (1) | BR112014008303A2 (https=) |
| CA (1) | CA2846905A1 (https=) |
| EA (1) | EA201490502A1 (https=) |
| ES (1) | ES2862576T3 (https=) |
| IL (1) | IL231032A0 (https=) |
| MX (1) | MX356956B (https=) |
| SG (1) | SG11201400656SA (https=) |
| TW (1) | TWI583788B (https=) |
| WO (1) | WO2013040444A1 (https=) |
| ZA (1) | ZA201401655B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU765203B2 (en) | 1999-04-19 | 2003-09-11 | Shionogi & Co., Ltd. | Sulfonamide derivatives having oxadiazole rings |
| AU2015269365A1 (en) | 2014-06-04 | 2016-12-15 | Amgen Inc. | Methods for harvesting mammalian cell cultures |
| PL3865563T3 (pl) | 2014-11-25 | 2024-01-29 | Corning Incorporated | Materiały i sposoby do przedłużania pożywki do hodowli komórkowej |
| CA2969225C (en) | 2014-12-01 | 2023-08-22 | Amgen Inc. | Process for manipulating the level of glycan content of a glycoprotein |
| WO2016183016A1 (en) * | 2015-05-08 | 2016-11-17 | Flownamics Analytical Instruments, Inc. | Method & apparatus for continuous automated perfusion system harvesting from in-situ filtration probe |
| WO2021097281A1 (en) | 2019-11-15 | 2021-05-20 | Lonza Ltd | Process and system for producing an inoculum |
| US20230287335A1 (en) | 2020-07-30 | 2023-09-14 | Amgen Inc. | Cell culture media and methods of making and using the same |
| CN112553044A (zh) * | 2020-12-10 | 2021-03-26 | 上海奥浦迈生物科技股份有限公司 | 一种生物反应器细胞培养进样口用防堵塞装置 |
| KR20250056246A (ko) * | 2022-10-13 | 2025-04-25 | 가부시키가이샤 히타치세이사쿠쇼 | 배양 장치의 제어 방법, 및 세포 배양을 수반하는 배양 장치의 제어 방법 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629202A (en) | 1994-07-19 | 1997-05-13 | Development Center For Biotechnology | Computer-controlled bioreactor system for enzymatic synthesis of L-tryptophan |
| DE102004007658A1 (de) | 2004-02-17 | 2005-09-01 | Bioceuticals Arzneimittel Ag | Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen |
| WO2007071072A1 (en) | 2005-12-22 | 2007-06-28 | Corporation De L'ecole Polytechnique De Montreal | High-rate perfusion bioreactor |
| JP2007202500A (ja) | 2006-02-03 | 2007-08-16 | Hitachi Ltd | 培養槽の運転制御装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE241695T1 (de) * | 1996-03-13 | 2003-06-15 | Delta Biotechnology Ltd | Gärungs-steuerungssysteme |
| WO1998041611A1 (en) | 1997-03-20 | 1998-09-24 | Regents Of The University Of Minnesota | Process for the continuous culture of cells |
| CN1678731A (zh) * | 2002-08-27 | 2005-10-05 | 范德比尔特大学 | 多室生物反应器 |
| CN1778903A (zh) | 2005-09-29 | 2006-05-31 | 华东理工大学 | 一种动物细胞高密度连续灌注培养方法 |
| WO2008136398A1 (ja) | 2007-04-26 | 2008-11-13 | Chugai Seiyaku Kabushiki Kaisha | 高濃度アミノ酸含有培地を用いた細胞の培養方法 |
-
2012
- 2012-09-14 TW TW101133866A patent/TWI583788B/zh active
- 2012-09-14 MX MX2014003134A patent/MX356956B/es active IP Right Grant
- 2012-09-14 EA EA201490502A patent/EA201490502A1/ru unknown
- 2012-09-14 AU AU2012308335A patent/AU2012308335A1/en not_active Abandoned
- 2012-09-14 KR KR1020147005482A patent/KR101710766B1/ko active Active
- 2012-09-14 ES ES12766802T patent/ES2862576T3/es active Active
- 2012-09-14 JP JP2014530890A patent/JP2014526265A/ja active Pending
- 2012-09-14 SG SG11201400656SA patent/SG11201400656SA/en unknown
- 2012-09-14 BR BR112014008303A patent/BR112014008303A2/pt not_active IP Right Cessation
- 2012-09-14 EP EP12766802.8A patent/EP2756069B1/en active Active
- 2012-09-14 WO PCT/US2012/055552 patent/WO2013040444A1/en not_active Ceased
- 2012-09-14 CN CN201280044589.4A patent/CN103946366B/zh active Active
- 2012-09-14 CA CA2846905A patent/CA2846905A1/en not_active Abandoned
- 2012-09-14 US US14/342,304 patent/US9803166B2/en active Active
-
2014
- 2014-02-18 IL IL231032A patent/IL231032A0/en unknown
- 2014-03-05 ZA ZA2014/01655A patent/ZA201401655B/en unknown
-
2016
- 2016-09-30 JP JP2016193713A patent/JP2017029162A/ja active Pending
-
2019
- 2019-10-24 JP JP2019193185A patent/JP2020022492A/ja active Pending
-
2022
- 2022-01-21 JP JP2022007644A patent/JP2022058710A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629202A (en) | 1994-07-19 | 1997-05-13 | Development Center For Biotechnology | Computer-controlled bioreactor system for enzymatic synthesis of L-tryptophan |
| DE102004007658A1 (de) | 2004-02-17 | 2005-09-01 | Bioceuticals Arzneimittel Ag | Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen |
| WO2007071072A1 (en) | 2005-12-22 | 2007-06-28 | Corporation De L'ecole Polytechnique De Montreal | High-rate perfusion bioreactor |
| JP2007202500A (ja) | 2006-02-03 | 2007-08-16 | Hitachi Ltd | 培養槽の運転制御装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI583788B (zh) | 2017-05-21 |
| WO2013040444A1 (en) | 2013-03-21 |
| AU2012308335A1 (en) | 2014-03-13 |
| JP2022058710A (ja) | 2022-04-12 |
| EA201490502A1 (ru) | 2014-06-30 |
| IL231032A0 (en) | 2014-03-31 |
| MX356956B (es) | 2018-06-21 |
| CN103946366B (zh) | 2017-08-11 |
| SG11201400656SA (en) | 2014-04-28 |
| BR112014008303A2 (pt) | 2017-04-11 |
| ES2862576T3 (es) | 2021-10-07 |
| TW201326387A (zh) | 2013-07-01 |
| KR20140044396A (ko) | 2014-04-14 |
| US20140295545A1 (en) | 2014-10-02 |
| US9803166B2 (en) | 2017-10-31 |
| EP2756069A1 (en) | 2014-07-23 |
| JP2020022492A (ja) | 2020-02-13 |
| JP2014526265A (ja) | 2014-10-06 |
| EP2756069B1 (en) | 2021-01-27 |
| MX2014003134A (es) | 2014-04-25 |
| JP2017029162A (ja) | 2017-02-09 |
| CA2846905A1 (en) | 2013-03-21 |
| ZA201401655B (en) | 2014-12-23 |
| CN103946366A (zh) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101710766B1 (ko) | 세포 배양물의 사전-예정된 비-피이드백 조절된 연속 공급 | |
| JP7566995B2 (ja) | 乳酸塩の蓄積を予防しつつ、細胞培養物を増殖させるための方法及びシステム | |
| Hsu et al. | Advanced microscale bioreactor system: a representative scale-down model for bench-top bioreactors | |
| JP2026063384A (ja) | 細胞培養におけるプロセス変量を制御するためのインサイチュラマン分光システム及び方法 | |
| Neunstoecklin et al. | Determination of the maximum operating range of hydrodynamic stress in mammalian cell culture | |
| CN112662551B (zh) | 一种细胞培养控制方法以及系统 | |
| Streefland et al. | Process analytical technology (PAT) tools for the cultivation step in biopharmaceutical production | |
| EP3841193A1 (en) | A process for creating reference data for predicting concentrations of quality attributes | |
| JP6096123B2 (ja) | ヒト骨髄性白血病細胞およびそれに由来する細胞を培養するための方法 | |
| US20160274111A1 (en) | Device and method for culturing cells | |
| Gilbert et al. | Identifying and eliminating cell culture process variability | |
| Martínez-Monge et al. | A new strategy for fed-batch process control of HEK293 cell cultures based on alkali buffer addition monitoring: comparison with OUR dynamic method | |
| Sagmeister et al. | Bacterial suspension cultures | |
| Xu et al. | Antibody charge variant modulation by in vitro enzymatic treatment in different Chinese hamster ovary cell cultures | |
| Oosterhuis et al. | How multipurpose is a disposable bioreactor | |
| Akram | Culturing of Animal Cells, Stem Cells, Tissues, and Organs for Industrial Products: An Introduction | |
| Ducrey et al. | Developing an automatically controlled feeding process in an E. coli fermentation process for recombinant protein production | |
| Kang | Analysis of Heterogeneities in a 20 L Bioreactor | |
| Wolf | Development and optimization of mammalian cell perfusion cultures for continuous biomanufacturing | |
| Deuschitz | Characterization of the redox environment in protein refolding processes | |
| Yun et al. | Continuous stable production of von Willebrand Factor monoclonal antibody in spin filter bioreactor with bleeding technology | |
| Pareek | Fed-batch bio-process development and optimization of cetuximab production at lab scale | |
| CN120380163A (zh) | 用于生产糖蛋白组合物的方法 | |
| TW202405159A (zh) | 用於治療性產品製造的靈活的設施配置 | |
| EA051642B1 (ru) | КАЛИБРОВКА И КОРРЕКЦИЯ pH-МЕТРА |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0105 | International application |
Patent event date: 20140228 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20160112 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20161124 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170221 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20170221 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| FPAY | Annual fee payment |
Payment date: 20200115 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200115 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210115 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220125 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240130 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250210 Start annual number: 9 End annual number: 9 |